SANDRENA (Orion Pharma (AUS) Pty Limited)
Product name
SANDRENA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
158 (255 working days)
Active ingredients
estradiol hemihydrate
Registration type
EOI
Indication
Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.